Advanced Russian hemostasis diagnostics effort raises new funding

HemaCore, a Moscow-based biotech company, has raised another $3m for the development of its new hemostasis diagnostics equipment for a variety of medical applications

HemaCore, a Moscow-based biotech company, raised last month another $3m in a loan to help further the development of its new hemostasis diagnostics equipment for a variety of medical applications, the Russian company announced. According to the developer, prior rounds of funding between October 2010 and now assisted the company in developing and looking into the properties of its new diagnostic testing method, and also in setting up small-scale production of method-based instruments and related expendables. HemaCore is not disclosing the names of its investors at this point. This most recent loan is expected to facilitate the completion of current clinical trials and help create a dealership network...